|
|
||||||||
1 Division of Kinesiology, School of Kinesiology and Leisure Studies, University of Minnesota, Minneapolis 55455; 2 Department of Laboratory Medicine and Pathology, School of Medicine, University of Minnesota, Hennepin County Medical Center, Minneapolis 55404; and 3 Jesse E. Edwards Registry of Cardiovascular Disease, St. Paul, Minnesota 55102
| |
ABSTRACT |
|---|
|
|
|---|
The goal of this study was to determine whether the stress of forced exercise would result in injury to the myocardium. Male rats with 8% of body weight attached to the tail were forced to swim 3.5 h (3.5S), forced to swim 5 h (5S), or pretrained for 8 days and then forced to swim 5 h (T5S). Rats were killed immediately after they swam (0 h PS) and at 3 h (3 h PS), 24 h (24 h PS), and 48 h after they swam (48 h PS). Tissue homogenates of the left ventricle were analyzed by Western blot analysis for cardiac troponin T (cTnT). Serum cTnT was quantified by immunoassay. Results indicated that, in the 3.5S, 5S, and T5S groups, serum cTnT was significantly (P < 0.01) increased at 0 and 3 h PS. The 5S group demonstrated a greater increase in serum cTnT than the 3.5S group (P < 0.01) and the T5S group (P < 0.01) at 0 h PS. Western blot analysis indicated significant decreases (P < 0.01) in myocardial cTnT in the 5S group only at 0 h PS (P < 0.01) and 3 h PS (P < 0.05). Histological evidence of localized myocyte damage demonstrated by interstitial inflammatory infiltrates consisting of neutrophils, lymphocytes, and histiocytes, as well as vesicular nuclei-enlarged chromatin patterns, was observed in left ventricle specimens from the 5S group at 24 and 48 h PS. Our findings demonstrate that stressful, forced exercise induces alterations in myocardial cTnT and that training before exercise attenuates the exercise-induced heart damage.
myocardial damage; exercise stress; histology
| |
INTRODUCTION |
|---|
|
|
|---|
EPIDEMIOLOGICAL STUDIES have demonstrated that
regular exercise is associated with a reduction in the long-term risk
of myocardial events (19, 20, 27, 32). People who exercise regularly not only have a lower baseline risk of myocardial infarction but also
they have a lower risk that an infarction will be triggered by heavy
physical exertion (26). The overall risk of death from coronary heart
disease decreased about twofold in individuals who were physically
active compared with less active individuals (20). On the other hand,
heavy physical exercise has been recognized as a factor that triggers
severe myocardial events such as impaired ventricular performance (29),
cardiac ischemia (33, 34), myocardial infarction, and cardiac
arrest (37, 40, 42). In symptom-free men, the risk of fatal and
nonfatal heart attacks has been shown to be 4-56 times higher
during physical exercise than when seated at home reading a book (37,
47). Because 1,500,000 myocardial infarctions occur annually in the
United States (2),
75,000 infarctions that lead to 25,000 deaths may
occur soon after exercise (26, 41). However, no direct experimental
data are available to demonstrate that forced exercise can damage the
heart. Studies are limited by suitable animal models, as well as by
cardiac-specific markers that may be released into the circulation
after injury.
Cardiac troponin T (cTnT) and cardiac troponin I (cTnI) have unique amino acid sequences that differentiate them from their respective skeletal muscle isoforms (7, 48). These differences have allowed for the development of specific monoclonal antibodies that have been incorporated into immunoassays for detection of myocardial injury. Serum cTnT and cTnI have been used as specific markers for myocardial infarction (1, 3, 9, 22, 23) and ischemic injury (1, 9, 18, 49). Serum cTnT and cTnI measurements are specific in the assessment of cardiac injury in the presence of skeletal muscle damage (1). Increased concentrations of cTnT and cTnI in serum have been related to the extent of myocardial damage also (1, 9, 22, 23). Decreased myocardial cTnT concentrations also indicate heart damage, as demonstrated in dogs after coronary artery occlusion (34).
The purpose of the present study was threefold. First, we determined whether the stress of prolonged intense exercise would damage the heart. Second, we determined whether increased exercise volume would induce an increase in heart damage. Third, we determined whether training before prolonged intense exercise would have a protective effect on heart damage. Measurement of cTnT concentrations in the serum and myocardium of swimming rats was used as the marker for myocardial injury.
| |
RESEARCH DESIGN AND METHODS |
|---|
|
|
|---|
Animals and animal care. Male Sprague-Dawley rats (n = 143), weighing 285-335 g (body weight on the day before swimming), were used in these experiments. The rats were housed in cages in rooms regulated for temperature (23 ± 1°C), humidity (45-55%), and light cycle (0600-1800) and provided laboratory rat chow and water ad libitum. The research involving rodents in this study conforms with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and was approved by the Institutional Animal Care and Use Committee.
Experimental groups and exercise protocol. To attempt to minimize the general stress response of forced swimming, all rats were familiarized with swimming for 20 min (water temperature 35°C), without body weight attached to the rats, 2 days before any swimming protocols. The rats were then divided into three protocols. The first protocol consisted of 32 rats: 6 rats were used as sedentary controls and killed at rest, and 26 rats swam for 3.5 h (3.5S) in a swimming tank with 8% body weight (workload) attached to the tail. One rat was removed from this protocol when it was unable to finish the required forced swimming. After 3.5 h of swimming, the rats were towel dried, weighed, and killed immediately (0 h PS, n = 6), 3 h (3 h PS, n = 7), 24 h (24 h PS, n = 6), and 48 h after swimming (48 h PS, n = 6). The second protocol consisted of 63 rats: 12 rats were used as sedentary controls, and 51 rats swam for 5 h (5S) in a swimming tank with 8% body weight attached to the tail (25 or 26 rats swam together at each time). Three rats were removed from this protocol when they were unable to finish the required forced swimming. After the forced swimming, the rats were weighed and killed at 0 h PS (n = 12), 3 h PS (n = 12), 24 h PS (n = 12), and 48 h PS (n = 12). The third protocol consisted of 48 rats. The rats were pretrained for 8 days before a 5-h swim (T5S). Pretraining included 25 min of swimming on day 1 followed by an increase to 60 min on day 6 with no weight on the tail. The rats swam with a 5% tail weight for 20 min on day 7 and for 30 min on day 8. A 2-day rest period followed the training. Twelve rats were used as the pretrained control group; the other 36 rats swam for 5 h with 8% body weight attached to the tail (each time, 18 rats swam together). After the forced swimming, the rats were weighed and killed at 0 h PS (n = 12), 3 h PS (n = 12), and 48 h PS (n = 12). No rats were killed at 24 h PS in the T5S protocol. In all protocols, the 8% body weight load attached to the tail determined exercise intensity. The water temperature was 35°C, and the water depth was 26 cm.
Most of the rats could keep their noses and mouths constantly above the water surface by paddling with the legs during the first 3 h of swimming. The rats with better swimming ability were able to keep their bodies almost parallel to the water surface. The rats with poor swimming ability swam almost vertically against the water surface. Some of the rats were unable to keep their bodies floating in the water, occasionally would sink to the bottom of the swimming tank, and then would press the tank bottom forcefully with their hindlegs to keep their noses and mouths out the water. Some rats quickly learned this skill by sinking to the bottom for rest and then pushing on the bottom of tank with their hindlegs to keep their noses and mouths out of the water. Immediately after swimming, the rats were very tired but not exhausted, inasmuch as they were able to move around in the cage and soon to actively clean the water on their fur with their front legs and mouths. In all protocols, the body weights of the 48-h PS groups were monitored up to 48 h after exercise.Animal death and tissue sampling.
Rats were anesthetized with pentobarbital sodium (Nembutal, 50 mg/kg
ip). The abdominal cavity was quickly opened, and 10 ml of blood were
drawn out from the abdominal aorta. Serum samples were collected and
stored at
80°C for cTnT measurements. The chest cavity was
then quickly opened, and the heart was excised, frozen on dry ice, and
stored at
80°C until biochemical analysis for cTnT by
Western blot. Within each group, rats were killed within 30 min.
Sample preparation.
Frozen myocardial samples were cut into small pieces on dry ice-cooled
sample plates and then added to 2 ml of ice-cold buffer [200 mM
potassium phosphate (pH 7.4), 5.0 mM EGTA, 5.0 mM
-mercaptoethanol, and 10% (vol/vol) glycerol] (46). The samples were homogenized three times in an ice bath for 10 s each at high speed with a Polytron
tissue homogenizer (Brinkman Instruments, Westbury, NY) and then
centrifuged at 3,000 g for 30 min at 4°C. The procedure yielded >98% recovery of cytosolic and myofibril proteins (46). The
supernatants were used for Western blotting. Protein concentrations were determined using a modified Lowry method (21) with BSA as a
standard. Serum cTnT measurements were obtained using the Roche
second-generation cTnT immunoassay, which is 100% specific for cTnT
(5). No cross-reactivity was observed in the cTnT assay at high
concentrations of rat skeletal muscle troponin T (TnT; data not shown).
Precision (percent coefficient of variation) at the upper reference
limit for cTnT (0.1 µg/l) was <10%. The cTnT assay has been shown
to be linear from 0.01 ng/ml (lower limit of detection) to 50.0 ng/ml (upper limit of linearity). Furthermore, this assay has been
previously validated for use in several laboratory animals,
including rats (30).
Histological examination.
Left ventricular tissue was removed and immediately placed in 10%
buffered Formalin. The apex of the heart was also removed and
immediately frozen at
70°C after the animal was killed. The apex heart section remained frozen until preparation for histological examination, at which time it was placed in 10% buffered Formalin and
permitted to thaw. One or two hearts from each protocol, including controls, were chosen randomly from the different time periods. From
the randomly selected hearts, the entire apical segment and left
ventricular tissues were embedded in paraffin, sectioned at 5-µm
intervals, and stained with hematoxylin-eosin and/or trichrome stains.
Western blot analysis. Tissue homogenates were size fractionated on 12% SDS-polyacrylamide gels (43) and subsequently transferred to Hybond nitrocellulose membranes (Amersham, Arlington Heights, IL). Nonspecific binding sites were blocked by incubating the membranes in a blocking buffer [5.0% nonfat dry milk in Tris-buffered saline (TBS): 20 mM Tris · HCl (pH 7.6), 137 mM NaCl] for 1 h. A primary antibody specific for human cTnT (a gift from Fortron Bio-Scientific, Morrisville, NC) was diluted (1:1,000) in antibody buffer (1.0% nonfat dry milk in TBS) and incubated with the membranes for 2 h on a rotating cylinder. The membranes were washed three times with Tween-TBS for 30 min. Horseradish peroxidase-labeled secondary antibody (sheep anti-mouse IgG) was then incubated with the membranes for 1 h at a dilution of 1:3,000. The membranes were again washed three times in Tween-TBS buffer before a 1-min incubation with enhanced chemiluminescent substrate (Amersham). Light emission was detected by exposure to Fuji RX autoradiography film in the presence of Cronex intensifying screens. Signal intensities within the linear range were quantitated using laser densitometry (Molecular Dynamics, Sunnyvale, CA). Linearity was established by analysis of a standard curve generated with known amounts of proteins (with use of myocardial muscle homogenate) by Western blot. Myocardial cTnT was linear from 0.5- to 6-µg sample loading amounts of total protein. An excellent correlation (r = 0.99) between loading amounts and signal intensities of cTnT was obtained. To ensure that proteins on different sides of the gel were equally transferred, blotted, and detected, a control sample (pooled tissue samples) was loaded onto all the gels in at least two lanes as internal control (I) lanes, allowing for blotting quality control. Sample loading amount for cTnT was 2 µg/lane. Although there is a small amount of cross-reactivity against skeletal TnT with the Fortron antibody, rat skeletal TnT isoforms migrate distinctly to lower molecular weights and do not interfere in the determination of cTnT when the Fortron antibody is used (data not shown). However, no skeletal TnT isoforms were observed in the rat heart samples studied.
Statistical analysis. Data from all groups were analyzed using a two-way ANOVA to determine main effects across time after swimming. Tukey's post hoc test for multiple comparisons was used to determine significant differences from preexercise values when significant main effects were found. Significance was set at P < 0.05. Values are means ± SD unless stated otherwise. The values of Western blot are presented as percentage of the control group.
| |
RESULTS |
|---|
|
|
|---|
Figure 1 shows that body weight was
maximally decreased (P < 0.01) at 0 h PS for all three
protocols: 7.4% after the 3.5S protocol, 9.4% after the 5S protocol,
and 9.9% after the T5S protocol. Body weights remained decreased
(P < 0.01) up to 24 h PS in the 3.5S protocol, up to 48 h PS
in the 5S protocol, and up to 24 h PS in the T5S protocol.
|
Figure 2 shows that serum cTnT
concentrations increased significantly (P < 0.01) above
control concentrations (0.01 µg/l) after all three protocols at 0 and
3 h PS. The largest increases occurred in the 5S protocol, with a peak
cTnT concentration of 0.15 ± 0.07 (range 0.06-0.26) µg/l at 0 h PS. This increase was significantly (P < 0.01) greater than
any other cTnT increase in the 3.5S (mean 0.04 µg/l, range
0.03-0.06 µg/l) and T5S (mean 0.06 µg/l, range 0.03-0.12
µg/l) groups. The increases in the 3.5S and T5S groups at 0 and 3 h
PS were not significantly different.
|
Figure 3 shows a representative Western blot analysis of
cTnT in the 0, 3, 24, and 48 h PS groups after the 5S protocol. One cTnT band migrated to a molecular weight position corresponding to
~40 kDa. An internal control sample, I, was used to confirm equivalence of protein transfer across each gel. Skeletal TnT isoforms
were not detected.
|
Figure 4 shows the changes in cTnT
determined by Western blot analysis in left ventricles after the 3.5S,
5S, and T5S protocols. cTnT did not significantly decrease after the
3.5S and T5S protocols. However, after the 5S protocol, cTnT decreased
14% (arbitrary scanning units 3,729 ± 153, P < 0.01) and
10% (arbitrary scanning units 3,909 ± 156, P < 0.05) at 0 and 3 h PS, respectively, compared with controls (arbitrary scanning
units 4,349 ± 174). Furthermore, cTnT in the 5S protocol was
significantly decreased 10% (P < 0.05) compared with the
same PS groups in the 3.5S and T5S protocols. By 24 h PS, cTnT
concentrations returned to preexercise control values.
|
As shown in Fig. 5, within the wall of the
left ventricular myocardium, there are foci of myocyte injury with an
interstitial inflammatory infiltrate consisting of neutrophils,
lymphocytes, and histiocytes, as well as vesicular nuclei-enlarged
chromatin patterns. These foci of myocyte injury in the left ventricles were observed in only four rats in the 5S group at 24 and 48 h PS.
Furthermore, no histological evidence of recent or remote ischemic
damage was evident in any of the apical sections examined.
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study demonstrates that cTnT is released into the circulation from rat myocardium after 3.5 h of forced swimming, indicative of myocardial injury. Furthermore, an increase in exercise volume from 3.5 to 5 h of forced swimming resulted in a larger increase of circulating cTnT, indicative of a greater amount of myocardial injury compared with the 3.5-h model. However, an 8-day period of conditioning or pretraining before the 5-h forced swim resulted in a significant decrease in the release of cTnT into the circulation (Fig. 2) compared with the 5-h swimming protocol without pretraining, indicative of less myocardial injury than the 5-h model. Concordant with these findings, myocardial (left ventricle) cTnT concentrations were significantly decreased at 0 and 3 h PS in the 5S protocol, and histological evidence of myocyte damage in the 5S group at 24 and 48 h PS was also observed (Fig. 5). However, no measurable myocardial tissue loss of cTnT or histological evidence of damage was noted in the 3.5S or T5S protocol at any time period. These studies appear to be unique in studying the alteration of cTnT in myocardial tissue and serum after a stressful, forced swimming exercise protocol. Our findings are in agreement with recent findings in humans, in which ultraendurance exercise (Hawaii Ironman Triathlon) was demonstrated to cause myocardial damage, as indicated by increased serum cTnI and cTnT concentrations and alterations in echocardiography in 6 of 23 athletes immediately after the event (36). The cellular nature of damage in this study was not examined.
Our finding raises several questions. First, were the increased serum concentrations of cTnT in the 3.5S and T5S protocols, which do not show loss of myocardial cTnT, due to reversible or irreversible ischemic injury to the heart? Second, do the increased serum concentrations of cTnT in the 5S protocol, which does correspond to myocardial tissue loss of cTnT, represent a necrotic, irreversible injury to the heart? Serum cTnT is a highly sensitive and specific marker for myocardial injury in humans and animals (23, 28, 34, 46, 49). Serum cTnT is measured in the present study by the second-generation cTnT immunoassay from Roche, which is 100% specific for the heart, with no cross-reactivity against human skeletal muscle TnT (5, 35) or rat skeletal muscle TnT (data not shown). It is interesting to observe that serum cTnT concentrations in the 3.5S, 5S, and T5S protocols peaked ~5-6 h after the initiation of exercise. Thus the exercise volume and the release kinetics of cTnT from myocardial tissue into the circulation are likely responsible for the increased serum cTnT. The cTnT release patterns we observed in rats appear similar to those observed after injury to the myocardium after myocardial infarction in humans, in that 4-8 h are required for cTnT to become increased in the serum after the myocardial insult (23, 44, 49). Furthermore, serum cTnT concentrations in the three protocols returned to baseline concentrations by 24 h. We hypothesize that the rapid return to baseline suggests that release of cTnT from the exercise-induced myocardial injury is likely from localized minor, irreversible myocyte degeneration, since large irreversible injury to myocardial tissue after myocardial infarction in humans and in animal models remains increased for 5-10 days (22, 34, 49). The rapid increase and normalization of serum cTnT in our exercise model likely represent the loss of the 2-8% cytoplasmic compartment of cTnT, which has a half-life of <6 h (16, 46). The rapid normalization of cTnT to preexercise control values by 24 h of the decreased myocardium at 0 h PS in the 5S protocol likely is due to a reequilibration between the 95% myofibril compartment and the depleted 5% cytoplasmic cTnT compartment.
Histological evidence of myocyte damage in the left ventricles from four rats in the 5S group at 24 and 48 h PS demonstrated by inflammatory infiltrates of neutrophils, lymphocytes, and histiocytes and vesicular nuclei-enlarged chromatin patterns supports the hypothesis that loss of cTnT into the circulation is due to myocardial damage. No ischemic changes were identified histologically in any of the apical heart specimens for any of the time intervals after exercise, regardless of the duration of exercise. It is possible that the apex of the heart is not the best area for histopathological observations. However, the apex specimens were frozen before histological examination, which may have interfered with interpretation. Initial signs of ischemia, myocyte hypereosinophilia, and prominent contraction bands are not evident until 4-6 h after the onset of ischemia. Therefore, ischemic changes were not expected histologically in rats killed 0 or 3 h after exercise. The foci of myocyte injury, as shown in Fig. 5, are likely irreversible, suggestive of myocarditis, and may not always be identifiable by limited light-microscopic examination. No electron-microscopic examination was performed in this study. Mechanisms responsible for the myocyte injury were not studied.
Studies have shown that exercise of short duration induced regional myocardial dysfunction in dogs with severe coronary stenosis or ventricular hypertrophy (13-15). Repetitive episodes of exercise-induced ischemia resulted in cumulative postexercise regional myocardial dysfunction that lasted >2 h after the last episodes of exercise (14). Unfortunately, no serum biochemical markers for myocardial injury were tested in the above studies. Epidemiological studies have confirmed that heavy physical exertion can trigger myocardial infarction (26, 38). Studies also have shown that prolonged intense exercise can induce impaired left ventricular function and silent myocardial ischemia in some athletes (8, 17, 29, 36). However, most studies failed to show elevation of serum cTnT in symptomless athletes after marathon or ultramarathon running (1, 24, 39).
Our findings regarding alterations of the cardiac contractile protein
cTnT after the prolonged single bout of forced swimming in rats are
likely due to the development of our high-intensity (imposed tail
weight) model, as well as the effect of severe stress placed on the
rats. Our unpublished data indicated that rats swimming with 8% body
weight attached to the tail generate a blood lactate (a marker for
exercise intensity) concentration of 7.2 mM (vs. nonswimming control
concentration of 3.7 mM), whereas rats run on a treadmill at 25 m/min
fail to show any significant increase in blood lactate. A blood
lactate level of 7 mM was reported in rats running up a 16° incline
at a speed of 50 m/min with O2 uptake of ~110
ml · kg
1 · min
1
(4). Furthermore, a maximal O2 uptake of ~80
ml · kg
1 · min
1
was obtained from the swimming rats with 2% body weight attached to
the tail (25). In comparison, the exercise intensity in our swimming
model was four times higher than that with 2% body weight attached to
the tail. Our study shows that a 40% increase of total exercise volume
from 3.5 to 5 h of swimming resulted in an increase in serum cTnT from
0.04 µg/l to 0.15 ng/l (3.5 times above the cTnT concentration in the
3.5S group) immediately after swimming. The mechanism for this finding
is not totally clear. It may relate to the different metabolic
processes between the early and late stages of prolonged exercise,
including depletion of glycogen stores (11, 12), alterations in glucose
and fatty acid utilization (12), calcium alteration (6), free
radical-mediated injury (45), and prolonged elevation of circulating
catecholamines. Furthermore, no studies were undertaken to study
whether there was evidence of impairment of cardiac function. However,
numerous studies in the literature now clearly demonstrate the
important prognostic role of increased serum cTnT levels in predicting
short and long cardiac events in patients presenting with ischemic
chest pain (10, 31). Furthermore, in an acute myocardial infarction study involving a dog model, increases in serum cTnT correlated with
loss of myocardial cTnT (34). Thus, in humans, there appears to be an
important physiological message for which medical and pharmacological
management decisions are now influenced by increased serum cTnT values.
We also demonstrated a significant protective effect on prolonged exercise-induced myocardial damage as a consequence of the pretraining. In this study, the rats were pretrained for 8 days. Immediately after swimming, serum cTnT concentration in pretrained rats was 60% lower than in the untrained rats [0.06 µg/l in trained rats (T5S) vs. 0.15 µg/l in untrained rats (5S)]. Pretraining also blunted any decrease in myocardial cTnT after 5 h of swimming. These data suggest that even a short-term, low exercise volume of physical training could significantly protect the heart from prolonged, intense exercise-induced myocardial damage. Comparatively, in humans, the effect of regular physical exercise (preconditioning) may be very important. Our data may help in understanding the effect of regular physical exercise in reducing the long-term risk of myocardial events and the fact that people who are physically active have a lower risk of myocardial events triggered by heavy physical exertion (26).
In conclusion, our study shows that a single bout of stressful, prolonged, intense exercise induced damage as monitored by cTnT in the heart and serum in the myocardium of rats. Furthermore, an increase in exercise volume induced more myocardial damage, and training before stressful, prolonged, intense exercise provided protection from myocardial damage.
| |
ACKNOWLEDGEMENTS |
|---|
Roche Diagnostics kindly provided the cTnT immunoassay kits.
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: F. S. Apple, Hennepin County Medical Center, Clinical Labs #812, 701 Park Ave., Minneapolis, MN 55404 (E-mail: fred.apple{at}co.hennepin.mn.us).
Received 4 May 1999; accepted in final form 8 December 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adams, EJ, III,
Bodor GS,
Davila-Roman VG,
Delmez JA,
Apple FS,
Ladenson JH,
and
Jaffe AS.
Cardiac troponin I
a marker with high specificity for cardiac injury.
Circulation
88:
101-106,
1993
2.
American Heart Association.
Heart and Stroke Facts. Dallas, TX: Am. Heart Assoc. Natl. Center, 1992.
3.
Apple, FS,
Falahati A,
Paulsen PR,
Miller EA,
and
Sharkey SW.
Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I.
Clin Chem
43:
2047-2051,
1997
4.
Armstrong, RB,
Laughlin MH,
Rome L,
and
Taylor CR.
Metabolism of rats running up and down an incline.
J Appl Physiol
55:
518-521,
1983
5.
Baum, H,
Braun S,
Gerhardt W,
Gilson G,
Hafner G,
Muller-Bardorff M,
Stein W,
Klein G,
Ebert C,
Hallermayer K,
and
Katus HA.
Multicenter evaluation of a second-generation assay for cardiac troponin T.
Clin Chem
43:
1877-1884,
1997
6.
Chen, YJ,
Zhang DT,
Guo QF,
Wei JP,
and
Serfass C.
Effects of prolonged high intensity running on myocardium in untrained rats (Abstract).
Med Sci Sports Exerc
29:
246,
1997.
7.
Dhoot, GK,
Grearson N,
and
Perry SV.
Polymorphic forms of troponin T and troponin C and their localization in striated muscle cell types.
Exp Cell Res
122:
339-350,
1979[Web of Science][Medline].
8.
Douglas, PS,
O'Toole ML,
Hiller WD,
Hackney K,
and
Reichek N.
Cardiac fatigue after prolonged exercise.
Circulation
76:
1206-1213,
1987
9.
Feng, YJ,
Chen C,
Fallon JT,
Lai T,
Chen L,
Knibbs DR,
Waters DD,
and
Wu AHB
Comparison of cardiac troponin I, creatine kinase-MB and myoglobin for detection of acute ischemic myocardial injury in a swine model.
Am J Clin Pathol
110:
70-77,
1998[Web of Science][Medline].
10.
Hamm, CW,
Heeschen C,
Goldman B,
Vahanin A,
Adgey J,
and
Miguel CM.
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels.
N Engl J Med
340:
1623-1629,
1999
11.
Hargreaves, M.
Interactions between muscle glycogen and blood glucose during exercise.
Exerc Sport Sci Rev
25:
21-39,
1997[Medline].
12.
Hawley, JA,
Brouns F,
and
Jeukendrup A.
Strategies to enhance fat utilization during exercise.
Sports Med
25:
241-257,
1998[Web of Science][Medline].
13.
Hittinger, L,
Shannon RP,
Kohin S,
Manders WT,
Kelly P,
and
Vatner SF.
Exercise-induced subendocardial dysfunction in dogs with left ventricular hypertrophy.
Circ Res
66:
329-343,
1990
14.
Homans, DC,
Laxson DD,
Sublett E,
Lindstrom P,
and
Bache RJ.
Cumulative deterioration of myocardial function after repeated episodes of exercise-induced ischemia.
Am J Physiol Heart Circ Physiol
256:
H1462-H1471,
1989
15.
Homans, DC,
Sublett E,
Dai XZ,
and
Bache RJ.
Persistence of regional left ventricular dysfunction after exercise-induced myocardial ischemia.
J Clin Invest
77:
66-67,
1986.
16.
Katus, HA,
Remppis A,
Scheffold T,
Diederich KW,
and
Kuebler W.
Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction.
Am J Cardiol
67:
1360-1367,
1991[Web of Science][Medline].
17.
Koller, A,
Mair J,
Mair M,
Calzolari C,
Larue C,
and
Puschendorf B.
Diagnosis of myocardial injury in marathon runners.
Ann NY Acad Sci
752:
234-235,
1995[Web of Science][Medline].
18.
Kragten, JA,
Herments WT,
and
Dieijen-Visser MP.
Cardiac troponin T release into plasma after acute myocardial infarction: only fractional recovery compared with enzymes.
Ann Clin Biochem
33:
314-323,
1996.
19.
Lee, IM,
Manson JE,
Hennekens CH,
and
Paffenbarger RS, Jr.
Body weight and mortality. A 27-year follow-up of middle-aged men.
JAMA
270:
2823-2828,
1993
20.
Leon, AS,
Connett J,
Jacobs DR, Jr,
and
Rauramaa R.
Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial.
JAMA
258:
2388-2395,
1987
21.
Lowry, OH,
Rosebrough NJ,
Farr AL,
and
Randall RJ.
Protein measurement with the Folin phenol reagent.
J Biol Chem
193:
265-275,
1951
22.
Mair, J,
Genser N,
and
Morandell D.
Cardiac troponin I in the diagnosis of myocardial injury and infarction.
Clin Chim Acta
245:
19-38,
1996[Web of Science][Medline].
23.
Mair, J,
Puschendorf B,
and
Michel G.
Clinical significance of cardiac contractile proteins for the diagnosis of myocardial injury.
Adv Clin Chem
131:
63-98,
1994.
24.
Mair, J,
Schobersberger W,
Koller A,
Bialk P,
Villiger B,
Frey W,
and
Puschendorf B.
Risk for exercise-induced myocardial injury for athletes performing prolonged strenuous endurance exercise.
Am J Cardiol
80:
543-544,
1997[Web of Science][Medline].
25.
McArdle, WD.
Metabolic stress of endurance swimming in the laboratory rat.
J Appl Physiol
22:
50-54,
1967
26.
Mittleman, MA,
Maclure M,
Tofler GH,
Sherwood JB,
Goldberg RJ,
and
Muller JE.
Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion.
N Engl J Med
329:
1677-1683,
1993
27.
Morris, JN,
Clayton DG,
Everitt MG,
Semmence AM,
and
Burgess EH.
Exercise in leisure time: coronary attack and death rates.
Br Heart J
63:
325-334,
1990
28.
Newby, LK,
Christenson RH,
Ohman EM,
Armstrong PW,
Thompson TD,
Lee KL,
Hamm CW,
Katus HA,
Cianciolo C,
Granger CB,
Topol EJ,
and
Califf RM.
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes.
Circulation
98:
1853-1859,
1998
29.
Niemelä, KO,
Palatsi I,
Ikäheima M,
Airaksined J,
and
Takkunen J.
Impaired left ventricular diastolic function in athletes after utterly strenuous prolonged exercise.
Int J Sports Med
8:
61-65,
1987.
30.
O'Brien, PJ,
Dameron GW,
and
Beck ML.
Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponin T immunoassays.
Res Vet Sci
65:
135-137,
1998[Web of Science][Medline].
31.
Ohman, EM,
Armstrong PW,
Christenson RH,
Granger CB,
Katus HA,
Hamm CW,
O'Hanesian MA,
Wagner GS,
Kleiman NS,
Harrell FE, Jr,
Califf RM,
and
Topol EF.
Cardiac troponin T levels for risk stratification in acute myocardial ischemia.
N Engl J Med
335:
133-141,
1996
32.
Paffenbarger, RS,
Wing AL,
and
Hyde PT.
Physical activity as an index of heart attack risk in college alumni.
Am J Epidemiol
8:
161-175,
1978.
33.
Rama, D,
Margaritis I,
and
Orsetti A.
Troponin I immunoenzymometric assays for the detection of muscle damage: application to the monitoring of a triathlon.
Clin Chem
42:
2033-2035,
1996
34.
Ricchiuti, V,
Sharkey S,
Murakami M,
Voss E,
and
Apple FS.
Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size.
Am J Clin Pathol
110:
241-247,
1998[Web of Science][Medline].
35.
Ricchiuti, V,
Voss E,
Ney A,
Odland M,
Anderson PAW,
and
Apple FS.
Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false positive results by second generation cardiac T assay by Boerhinger Mannheim.
Clin Chem
44:
1919-1924,
1998
36.
Rifai, N,
Douglas PS,
O'Toole M,
Rimm E,
and
Ginsburg GS.
Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon.
Am J Cardiol
83:
1085-1089,
1999[Web of Science][Medline].
37.
Shephard, RJ.
Sudden death
a significant hazard?
Sports Med
8:
101-110,
1974.
38.
Siegel, AJ,
Lewandrowski KB,
Strauss HW,
Fischman AJ,
and
Yasuda T.
Normal postrace antimyosin myocardial scintigraphy in asymptomatic marathon runners with elevated serum creatine kinase MB isoenzyme and troponin T levels. Evidence against silent myocardial cell necrosis.
Cardiology
86:
451-456,
1995[Web of Science][Medline].
39.
Siegel, AJ,
Scholar M,
Yang J,
Dhanak E,
and
Lewandrowski KB.
Elevated serum cardiac markers in asymptomatic marathon runners after competition: is the myocardium stunned?
Cardiology
88:
487-491,
1997[Web of Science][Medline].
40.
Siscovich, DS,
Weiss NS,
Fletcher RT,
and
Lasky T.
The incidence of primary cardiac arrest during vigorous exercise.
N Engl J Med
311:
874-877,
1984[Abstract].
41.
Tofler, GH,
Muller JE,
and
Stone PH.
Modifiers of timing and possible triggers of acute myocardial infarction in the thrombosis in myocardial infarction phase II (TIMI II) Study Group.
J Am Coll Cardiol
20:
1049-1055,
1992[Abstract].
42.
Tofler, GH,
Stone PH,
Maclure M,
Edelman E,
Davis VG,
Robertson T,
Antman EM,
and
Muller JE.
Analysis of possible triggers of acute myocardial infarction (the MILIS study).
Am J Cardiol
66:
22-27,
1990[Web of Science][Medline].
43.
Towbin, H,
Staehelin T,
and
Gordon J.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc Natl Acad Sci USA
76:
4350-4354,
1979
44.
Tucker, JF,
Collins RA,
Anderson AJ,
Haauser J,
Kalas J,
and
Apple FS.
Early diagnostic efficiency of cardiac troponin I and troponin T for acute myocardial infarction.
Acad Emerg Med
4:
13-21,
1997[Web of Science][Medline].
45.
Venditti, P,
and
Di Meo S.
Antioxidants, tissue damage, and endurance in trained and untrained young male rats.
Arch Biochem Biophys
331:
63-68,
1996[Web of Science][Medline].
46.
Voss, EM,
Sharkey SW,
Gernert A,
Murakami MA,
Johnson RB,
Hsieh CC,
and
Apple FS.
Human and canine cardiac troponin T and CK MB distribution in normal and diseased myocardium.
Arch Pathol Lab Med
119:
799-806,
1995[Web of Science][Medline].
47.
Vuori, I,
and
Suunakki T.
Risk of sudden death and sport.
Sports Med
1:
181-186,
1984[Web of Science][Medline].
48.
Wilkinson, JM,
and
Grand JA.
Comparison of amino acid sequence of troponin I from different striated muscles.
Nature
271:
31-35,
1978[Medline].
49.
Wu, AHB,
Valdes R,
Apple FS,
Gornet T,
Stone MA,
Mayfielf-Stokes S,
Ingersoll-Stroubos AM,
and
Wiler B.
Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction.
Clin Chem
40:
900-907,
1994
This article has been cited by other articles:
![]() |
A. La Gerche, A. J. Taylor, and D. L. Prior Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 350 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, M. M. Murakami, R. Ler, D. Walker, M. York, and for the HESI Technical Committee of Biomarkers Wor Analytical Characteristics of Commercial Cardiac Troponin I and T Immunoassays in Serum from Rats, Dogs, and Monkeys with Induced Acute Myocardial Injury Clin. Chem., December 1, 2008; 54(12): 1982 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
A La Gerche, K A Connelly, D J Mooney, A I MacIsaac, and D L Prior Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise Heart, July 1, 2008; 94(7): 860 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Rosa, E. Freymuller, S. S. M. Ihara, J. Aboulafia, and V. L. A. Nouailhetas Damaging effects of intense repetitive treadmill running on murine intestinal musculature J Appl Physiol, May 1, 2008; 104(5): 1410 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, A. Knapton, S. E. Lipshultz, J. L. Weaver, and E. H. Herman Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury Toxicol Pathol, February 1, 2008; 36(2): 277 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Circulation, April 3, 2007; 115(13): e356 - e375. [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Clin. Chem., April 1, 2007; 53(4): 552 - 574. [Full Text] [PDF] |
||||
![]() |
P. D. Thompson, F. S. Apple, and A. Wu Marathoner's Heart? Circulation, November 28, 2006; 114(22): 2306 - 2308. [Full Text] [PDF] |
||||
![]() |
L Tulloh, D Robinson, A Patel, A Ware, C Prendergast, D Sullivan, and L Pressley Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise--the Australian Ironman Triathlon Br. J. Sports Med., July 1, 2006; 40(7): 605 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Babuin and A. S. Jaffe Troponin: the biomarker of choice for the detection of cardiac injury Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. van der Laarse Hypothesis: troponin degradation is one of the factors responsible for deterioration of left ventricular function in heart failure Cardiovasc Res, October 1, 2002; 56(1): 8 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, H. E. Quist, A. P. Otto, W. E. Mathews, and M. M. Murakami Release Characteristics of Cardiac Biomarkers and Ischemia-modified Albumin as Measured by the Albumin Cobalt-binding Test after a Marathon Race Clin. Chem., July 1, 2002; 48(7): 1097 - 1100. [Full Text] [PDF] |
||||
![]() |
A. Koller Exercise-induced myocardial damage in humans J Appl Physiol, February 1, 2001; 90(2): 755 - 755. [Full Text] [PDF] |
||||
![]() |
A. S. Jaffe, J. Ravkilde, R. Roberts, U. Naslund, F. S. Apple, M. Galvani, and H. Katus It's Time for a Change to a Troponin Standard Circulation, September 12, 2000; 102(11): 1216 - 1220. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |